Clinical trial
The Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease - a Randomized, Placebo Controlled, Double Blinded, Multicentre, Clinical Trial
NCT00121550 is registered in ClinicalTrials.gov with Copenhagen Trial Unit, Center for Clinical Intervention Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease - a Randomized, Placebo Controlled, Double Blinded, Multicentre, Clinical Trial
- Lead sponsor
- Copenhagen Trial Unit, Center for Clinical Intervention Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 1999
- Completion date
- September 30, 2002
- Enrollment
- 4,372 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, heart disease